1. Home
  2. MGNI vs RGC Comparison

MGNI vs RGC Comparison

Compare MGNI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnite Inc.

MGNI

Magnite Inc.

N/A

Current Price

$24.37

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Logo Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited

HOLD

Current Price

$7.05

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGNI
RGC
Founded
2007
2014
Country
United States
Hong Kong
Employees
514
N/A
Industry
Computer Software: Programming Data Processing
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.1B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
MGNI
RGC
Price
$24.37
$7.05
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$25.22
N/A
AVG Volume (30 Days)
2.9M
149.4K
Earning Date
05-06-2026
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
493.75
N/A
EPS
0.16
N/A
Revenue
$156,414,000.00
N/A
Revenue This Year
$6.28
N/A
Revenue Next Year
$9.76
N/A
P/E Ratio
$153.70
N/A
Revenue Growth
25.45
N/A
52 Week Low
$10.82
$4.51
52 Week High
$26.19
$69.00

Technical Indicators

Market Signals
Indicator
MGNI
RGC
Relative Strength Index (RSI) 62.20 60.05
Support Level $11.26 $4.71
Resistance Level $25.41 $6.75
Average True Range (ATR) 0.99 0.45
MACD -0.12 0.25
Stochastic Oscillator 64.18 85.56

Price Performance

Historical Comparison
MGNI
RGC

About MGNI Magnite Inc.

Magnite is a supply-side advertising platform that provides technology and yield management solutions to content publishers, enabling them to monetize their digital advertising inventory. Magnite receives a percentage of all advertising inventory that it sells. 43% of Magnite's revenue is derived from connected television, or CTV, streaming platforms, 40% from mobile applications, and the remainder from general websites. Beyond the typical monetization responsibilities inherent to an SSP, Magnite also provides upstream advertising servers to CTV publishers, allowing them to have granular control over direct-sold, programmatic guaranteed, and open-auction logic. Magnite competes with other independent SSPs, supply path optimization solutions, and closed ecosystems like Meta.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: